Success Stories: Our Talented Team Helped an Indian Research Associate in Biomedical Science Get EB1-A Approval in a Little Over a Month, Thanks Also to the Premium Processing Upgrade
Client’s Testimonial:
“This is great news! I really appreciate all the help throughout my case.”
On November 23rd, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Associate in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Research Associate
Country of Origin: India
State of Residence at the Time of Filing: Michigan
Approval Notice Date: November 23rd, 2021
Processing Time: 1 month, 4 days (Premium Processing Requested)
Case Summary:
The EB1-A (Alien of Extraordinary Ability) application has clear-cut criteria for selection. The USCIS demands that anyone applying under this category needs to be able to demonstrate extraordinary ability in the sciences, arts, education, business, or athletics through sustained national or international acclaim. So when a client from India wanted to apply for his EB1-A approval, we made sure to include the following in his petition packet:
- We showed that he is one of the few leading inflammatory disease experts in biomedical sciences. He is especially well-known for his work on novel flavonoid-based biodegradable nanoparticles. Thus, indicating successfully his area of expertise and endeavor.
- We showed that he has actively engaged his peers in the field of biomedical sciences by authoring and co-authoring 18 peer-reviewed articles (8 of them first-authored and 1 of them co-first-authored) and 1 first-authored book chapter that has been published in an international journal.
- We were also able to point out that his published papers have been cited a total of 229 times already.
- Furthermore, we showed that the field has recognized his authority by inviting him to review and evaluate the work of his peers no fewer than 22 times.
- We also collected evidence of his major funding sources namely, the National Eye Institute, the United States Army Medical Research and Development Command, etc.
- And finally, we added 4 letters of recommendation from experts in the field who were familiar with him and his research work. This is what they say about our client and his work:
“With such positive receipt of his work, [client’s] research is clearly an important addition to the literature. The impact of his findings on related studies thus necessitates the continuation of his research in the United States.”
“[Client] has devised a formulation that swiftly treats eye injuries and can be administered without the involvement of a specialized medical professional. His research plays a critical role in preventing serious eye damage for civilians as well as military personnel, in turn helping to alleviate the economic burden of eye injury. As such, [client] is leading research that is of great value to the US economy and medical sector.”
“By advancing vaccine development, [client] has proven himself to be an invaluable asset to the pursuit of improving public health.”
These facts were supported by solid documentation from CVs, transcripts, testimonials, certificates, and so on. We are glad to have had the opportunity to represent him in this case and we thank him for choosing our firm to be a part of his success story.